Archives

by in
Entry Author Date Location
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend 08/02/12 Boston
Enlight Bio’s Knode Advances Social Network for Pharma 08/02/12 Boston
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
NanoString Makes IPO Prep Move, Adds Finance Vet to Board 07/18/12 Seattle
WebCollage Takes Ad Copy Mobile for Top Retailers 07/16/12 New York
In Search of Meaningful GAIN in Renewal of Prescription Drug Act 07/11/12 San Diego
Protagonist Criss-Crosses Pacific, in Search of New Peptide Drugs 07/11/12 San Francisco
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Context Matters Helps Pharma Execs Make Sense of Drug Data 06/20/12 New York
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Metabolic Solutions Announces New Findings in Diabetes Treatment 06/12/12 Detroit
The 2012 New York ASCO Checklist 05/24/12 New York
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab 05/04/12 New York
Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? 05/03/12 Seattle
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work 05/02/12 San Francisco
Pfizer Takes on Genzyme With New Gaucher Drug 05/02/12 Boston
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Boston and Cambridge Renew Rivalry in Startup Real Estate 04/13/12 Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
Transparency Launches as Linux of Drug Development 02/23/12 New York
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects 02/06/12 National
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
Four Themes to Watch in Personalized Medicine 01/30/12 San Francisco
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Page 3 of 16 « previous page · next page »